- Home
- DRCT vs ANVS Comparison
DRCT vs ANVS Comparison
Compare DRCT & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRCT
- ANVS
- Stock Information
- Founded
- DRCT 2018
- ANVS 2008
- Country
- DRCT United States
- ANVS United States
- Employees
- DRCT 79
- ANVS N/A
- Industry
- DRCT Computer Software: Programming Data Processing
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- DRCT Technology
- ANVS Health Care
- Exchange
- DRCT Nasdaq
- ANVS Nasdaq
- Market Cap
- DRCT 16.7M
- ANVS 24.2M
- IPO Year
- DRCT 2022
- ANVS 2020
- Fundamental
- Price
- DRCT $0.69
- ANVS $1.60
- Analyst Decision
- DRCT Strong Buy
- ANVS Strong Buy
- Analyst Count
- DRCT 1
- ANVS 4
- Target Price
- DRCT $6.00
- ANVS $40.67
- AVG Volume (30 Days)
- DRCT 2.9M
- ANVS 459.6K
- Earning Date
- DRCT 05-06-2025
- ANVS 05-20-2025
- Dividend Yield
- DRCT N/A
- ANVS N/A
- EPS Growth
- DRCT N/A
- ANVS N/A
- EPS
- DRCT N/A
- ANVS N/A
- Revenue
- DRCT $48,170,000.00
- ANVS N/A
- Revenue This Year
- DRCT $53.01
- ANVS N/A
- Revenue Next Year
- DRCT $11.11
- ANVS N/A
- P/E Ratio
- DRCT N/A
- ANVS N/A
- Revenue Growth
- DRCT N/A
- ANVS N/A
- 52 Week Low
- DRCT $0.44
- ANVS $1.11
- 52 Week High
- DRCT $6.59
- ANVS $17.88
- Technical
- Relative Strength Index (RSI)
- DRCT 48.55
- ANVS 52.79
- Support Level
- DRCT $0.81
- ANVS $1.42
- Resistance Level
- DRCT $1.23
- ANVS $1.75
- Average True Range (ATR)
- DRCT 0.14
- ANVS 0.18
- MACD
- DRCT 0.02
- ANVS 0.04
- Stochastic Oscillator
- DRCT 26.24
- ANVS 72.22
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform primarily focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.